Another go with more care and less haste
Not only is the market massive and growing for PD-1 inhibitors, the corporate need for new drugs that can differentiate PD-1 inhibitors is growing. So far the pricing of the PD-1 hasn’t broken, but it will be hard to maintain the price when there are 6 other near identical drugs the doctors can use.
Pillar 1 - FTO (new thread), page-874
-
- There are more pages in this discussion • 2,101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.92 |
Change
-0.025(1.29%) |
Mkt cap ! $326.2M | |||
| Open | High | Low | Value | Volume |
| $1.93 | $1.97 | $1.90 | $216.3K | 112.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14008 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.92 | 571 | 1 |
View Market Depth
| Last trade - 13.20pm 16/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |